272 related articles for article (PubMed ID: 29062069)
1. Resveratrol induces dephosphorylation of Tau by interfering with the MID1-PP2A complex.
Schweiger S; Matthes F; Posey K; Kickstein E; Weber S; Hettich MM; Pfurtscheller S; Ehninger D; Schneider R; Krauß S
Sci Rep; 2017 Oct; 7(1):13753. PubMed ID: 29062069
[TBL] [Abstract][Full Text] [Related]
2. Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling.
Kickstein E; Krauss S; Thornhill P; Rutschow D; Zeller R; Sharkey J; Williamson R; Fuchs M; Köhler A; Glossmann H; Schneider R; Sutherland C; Schweiger S
Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21830-5. PubMed ID: 21098287
[TBL] [Abstract][Full Text] [Related]
3. Active transport of the ubiquitin ligase MID1 along the microtubules is regulated by protein phosphatase 2A.
Aranda-Orgillés B; Aigner J; Kunath M; Lurz R; Schneider R; Schweiger S
PLoS One; 2008; 3(10):e3507. PubMed ID: 18949047
[TBL] [Abstract][Full Text] [Related]
4. Role of microtubule-associated protein tau phosphorylation in Alzheimer's disease.
Ma RH; Zhang Y; Hong XY; Zhang JF; Wang JZ; Liu GP
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):307-312. PubMed ID: 28585125
[TBL] [Abstract][Full Text] [Related]
5. The anti-diabetic drug metformin reduces BACE1 protein level by interfering with the MID1 complex.
Hettich MM; Matthes F; Ryan DP; Griesche N; Schröder S; Dorn S; Krauβ S; Ehninger D
PLoS One; 2014; 9(7):e102420. PubMed ID: 25025689
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
[TBL] [Abstract][Full Text] [Related]
7. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology.
Liu R; Zhou XW; Tanila H; Bjorkdahl C; Wang JZ; Guan ZZ; Cao Y; Gustafsson JA; Winblad B; Pei JJ
J Cell Mol Med; 2008; 12(1):241-57. PubMed ID: 18208556
[TBL] [Abstract][Full Text] [Related]
8. Mechanisms of tau-induced neurodegeneration.
Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
[TBL] [Abstract][Full Text] [Related]
9. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
Wang JZ; Grundke-Iqbal I; Iqbal K
Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
[TBL] [Abstract][Full Text] [Related]
10. Mig12, a novel Opitz syndrome gene product partner, is expressed in the embryonic ventral midline and co-operates with Mid1 to bundle and stabilize microtubules.
Berti C; Fontanella B; Ferrentino R; Meroni G
BMC Cell Biol; 2004 Feb; 5():9. PubMed ID: 15070402
[TBL] [Abstract][Full Text] [Related]
11. Sodium selenate specifically activates PP2A phosphatase, dephosphorylates tau and reverses memory deficits in an Alzheimer's disease model.
Corcoran NM; Martin D; Hutter-Paier B; Windisch M; Nguyen T; Nheu L; Sundstrom LE; Costello AJ; Hovens CM
J Clin Neurosci; 2010 Aug; 17(8):1025-33. PubMed ID: 20537899
[TBL] [Abstract][Full Text] [Related]
12. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
Iqbal K; Grundke-Iqbal I
Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
[TBL] [Abstract][Full Text] [Related]
13. Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A.
Zhou XW; Gustafsson JA; Tanila H; Bjorkdahl C; Liu R; Winblad B; Pei JJ
Neurobiol Dis; 2008 Sep; 31(3):386-94. PubMed ID: 18586097
[TBL] [Abstract][Full Text] [Related]
14. B vitamin deficiency promotes tau phosphorylation through regulation of GSK3beta and PP2A.
Nicolia V; Fuso A; Cavallaro RA; Di Luzio A; Scarpa S
J Alzheimers Dis; 2010; 19(3):895-907. PubMed ID: 20157245
[TBL] [Abstract][Full Text] [Related]
15. Molecular interactions among protein phosphatase 2A, tau, and microtubules. Implications for the regulation of tau phosphorylation and the development of tauopathies.
Sontag E; Nunbhakdi-Craig V; Lee G; Brandt R; Kamibayashi C; Kuret J; White CL; Mumby MC; Bloom GS
J Biol Chem; 1999 Sep; 274(36):25490-8. PubMed ID: 10464280
[TBL] [Abstract][Full Text] [Related]
16. TRAIL signals through the ubiquitin ligase MID1 to promote pulmonary fibrosis.
Collison AM; Li J; de Siqueira AP; Lv X; Toop HD; Morris JC; Starkey MR; Hansbro PM; Zhang J; Mattes J
BMC Pulm Med; 2019 Feb; 19(1):31. PubMed ID: 30732588
[TBL] [Abstract][Full Text] [Related]
17. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of microtubule assembly competent tubulin synthesis leads to accumulation of phosphorylated tau in neuronal cell bodies.
Fujiwara H; Watanabe S; Iwata M; Ueda S; Nobuhara M; Wada-Kakuda S; Misonou H; Miyasaka T
Biochem Biophys Res Commun; 2020 Jan; 521(3):779-785. PubMed ID: 31699369
[TBL] [Abstract][Full Text] [Related]
19. Insulin deprivation induces PP2A inhibition and tau hyperphosphorylation in hTau mice, a model of Alzheimer's disease-like tau pathology.
Gratuze M; Julien J; Petry FR; Morin F; Planel E
Sci Rep; 2017 Apr; 7():46359. PubMed ID: 28402338
[TBL] [Abstract][Full Text] [Related]
20. Molecular implication of PP2A and Pin1 in the Alzheimer's disease specific hyperphosphorylation of Tau.
Landrieu I; Smet-Nocca C; Amniai L; Louis JV; Wieruszeski JM; Goris J; Janssens V; Lippens G
PLoS One; 2011; 6(6):e21521. PubMed ID: 21731772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]